British American Tobacco PLC
12 December 2005
British American Tobacco Increases shareholding in Skandinavisk Tobakskompagni
British American Tobacco has today completed the transaction to increase its
shareholding in Skandinavisk Tobakskompagni (STK). As a result, the Group's
shareholding in STK will rise from 26.6 per cent to 32.3 per cent, at a purchase
price of €140 million (£95 million) payable in cash.
On 21 October 05, British American Tobacco announced its intention to excise its
pre-emption rights over part of Andresen Holdings' shareholding in Skandinavisk
Tobakskompagni (STK).
ENQUIRIES
British American Tobacco Press Office Investor Relations
David Betteridge / Teresa La Thangue / Emily Brand Ralph Edmondson/Rachael Cummins
+44 (0) 20 7845 2888 (24 hours) +44 (0) 20 7845 1180 or 1519
Notes to editors
• STK has been an associate company of British American Tobacco since 1972.
STK, a privately controlled company, is among Denmark's largest
international businesses and mainly engaged in the production and sales of
tobacco products.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.